The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) held a workshop Aug. 29-31 to discuss physiologically based biopharmaceutics modeling (PBBM).
The workshop, titled “Physiologically Based Biopharmaceutics Modeling (PBBM) Best Practices for Drug Product Quality: Regulatory and Industry Perspectives,” was held in a hybrid format with 190 in-person participants at the Universities at Shady Grove in Rockville, Md.
Read the full story on the School of Pharmacy's News Center.